Stuart Bressman

Partner Of Counsel, New York

Biography

Clients express warm approval of Stuart Bressman, describing him as “a skilled practitioner, makes sure things get solved and is a great collaborator on a transaction.”
Chambers USA, 2022

Overview

Stuart advises investment banks and issuers on public and private securities offerings by US and non-US companies. Clients also seek him out for his market-leading experience in alternative financing techniques, such as confidentially marketed public offerings, bought deals, registered direct offerings and private investments in public equity. Over his career, Stuart has completed hundreds of public offerings and private placements of securities as well as other kinds of transactions.

Stuart has particular experience across the biotechnology, pharmaceutical, technology and energy industries, and advises clients on corporate and securities compliance and reporting matters. Over his career, Stuart has advised on hundreds of public offerings and private placements of all kinds of securities for a variety of underwriters and issuers.

Bars and Courts
New York State Bar
Education
JD
Cornell Law School
AB
Cornell University
Languages
English

Experience

Representation of Oppenheimer & Co. Inc. as representative of the underwriters on the US$100 million initial public offering of 6,250,000 shares of Class A common stock by Backblaze, Inc. The underwriters have a 30-day option to purchase up to an additional 937,500 shares of Class A common stock. Oppenheimer & Co. Inc., William Blair & Company, L.L.C. and Raymond James & Associates, Inc. acted as lead book-running managers for this offering. JMP Securities LLC and B. Riley Securities, Inc. acted as joint book-running managers for this offering. Lake Street Capital Markets, LLC acted as co-manager for this offering. Backblaze, Inc. is a leading storage cloud platform, providing businesses and consumers cloud services to store, use, and protect their data in an easy and affordable manner.

Representation of Guggenheim Securities, LLC as representative of the underwriters in connection with the approximately US$116.0 million common stock, which includes the full exercise of the underwriters' over-allotment option in full, and $85.2 million pre-funded warrants offering by Infrastructure and Energy Alternatives, Inc. Guggenheim Securities, LLC, BMO Capital Markets Corp., CIBC World Markets Corp., and Fifth Third Securities, Inc. acted as the joint book-running managers for the offering, and D.A. Davidson & Co. and Thompson Davis & Co., Inc. acted as co-managers. Infrastructure and Energy Alternatives, Inc. is a leading infrastructure services company focused on renewable energy and transportation infrastructure.

Representation of Guggenheim Securities, LLC, as representative of the underwriters, on the US$75 million equity follow-on offering of 1,875,000 shares of Class A common stock of Chicken Soup for the Soul Entertainment, Inc. ("CSSE"). The underwriters have an over-allotment option for a period of 30 days to purchase 281,250 additional shares of Class A common stock of CSSE (for a total of 2,156,250 shares of Class A common stock). Guggenheim Securities, LLC and Needham & Company, LLC acted as joint book-running managers for the offering. Northland Securities, Inc., D.A. Davidson & Co., The Benchmark Company, LLC, Ladenburg Thalmann & Co. Inc. and Craig-Hallum Capital Group LLC acted as co-managers for the offering.

Representation of Oppenheimer & Co. Inc. as representative of the underwriters on the US$51.5 million follow-on offering of 7,360,000 shares of common stock (including the underwriters' full exercise of their option to purchase up to an additional 9,600,000 shares of common stock) of Ondas Holdings Inc., a provider of wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. Oppenheimer & Co. Inc. acted as the sole book-running manager for the offering, and B. Riley Securities, Inc. acted as lead manager for the offering.

Representation of J.P. Morgan Securities LLC, SVB Leerink LLC, BofA Securities, Inc., Evercore Group L.L.C. and RBC Capital Markets, LLC as representatives of the underwriters on the US$460.0 million follow-on offering of 10,952,381 shares of common stock (including the issuance of 1,428,571 shares as a result of the underwriters' full exercise of their option to purchase additional shares) of Intra-Cellular Therapies, Inc., a U.S. biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders.J.P. Morgan Securities LLC, SVB Leerink LLC, BofA Securities, Inc., Evercore Group L.L.C. and RBC Capital Markets, LLC acted as joint book-running managers for the offering. Cantor Fitzgerald & Co and Canaccord Genuity LLC acted as co-lead managers for the offering. Needham & Company, LLC acted as co-manager for the offering.

Represented Oppenheimer & Co. Inc. as representative of the underwriters in connection with the US$172.5 million follow-on offering of 5,750,000 shares of common stock (including the exercise of the option to purchase 750,000 additional shares) of GrowGeneration Corp. Oppenheimer & Co. Inc. and Stifel, Nicolaus & Company, Incorporated acted as the joint book-running managers for the offering and Craig-Hallum Capital Group LLC, Ladenburg Thalmann & Co. Inc. and Lake Street Capital Markets, LLC acted as co-managers for the offering. GrowGeneration Corp. is believed to be the largest chain of stand-alone hydroponic garden centers by revenue and number of stores in the United States.

Represented SVB Leerink LLC, Credit Suisse Securities (USA) LLC, Barclays Capital Inc. and Stifel, Nicolaus & Company, Incorporated as joint bookrunning managers in connection with the approximately US$345.1 million follow-on offering of 9,326,500 shares of common stock (including the exercise of the option to purchase an additional 1,216,500 shares) of Kura Oncology, Inc., a clincial-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Wedbush Securities Inc., JMP Securities LLC and H.C. Wainwright & Co., LLC also acted as co-managers in the offering.

Represented Jefferies LLC as sales agent in connection with the establishment of the "at-the-market" (ATM) offering program relating to the issuance and sale of shares of common stock from time to time, having aggregate sale proceeds of up to US$150.0 million by Sangamo Therapeutics, Inc., a clinical stage biotechnology company focused on translating ground-breaking science into genomic medicines with the potential to transform patients' lives using its platform technologies in gene therapy, ex vivo geneedited cell therapy, in vivo genome editing and in vivo genome regulation.

Representation of Cowen and Company, LLC, Wells Fargo Securities, LLC and Barclays Securities Inc. as underwriters in the US$145 million offering of 12,650,000 shares of common stock by Sangamo Therapeutics, Inc., a US clinical stage biotechnology company specializing in genomic medicine, including genome editing, gene regulation, gene therapy and cell therapy.

Awards and Recognition

Clients express warm approval of Stuart Bressman, "Stuart is very intelligent and a great attorney."

Chambers Global 2024

Chambers USA: Nationwide: Capital Markets: Debt & Equity 2009 – 2023

Chambers Global: USA: Capital Markets: Debt & Equity 2009 – 2024

The Legal 500: Capital Markets: Equity Offerings - 2023

New York Super Lawyers 2006 – 2020, 2022